Emerging patents versus brain eating amoebae, Naegleria fowleri
Küçük Resim Yok
Tarih
2025
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Taylor and Francis Ltd.
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Primary Amoebic Meningoencephalitis (PAM) is a severe and often fatal infection caused by the free-living amoebae Naegleria fowleri. This condition typically results from exposure to contaminated warm freshwater/inadequately treated recreational water/or ablution/nasal irrigation with contaminated water. The management of PAM is hindered by the absence of effective treatment coupled with challenges in early diagnosis. This review explores emerging patents that could be utilized for the treatment, diagnosis of PAM, as well as water treatment. Recent patents from the past five years, along with research and innovations are reviewed and categorized into therapeutic agents, water treatment technologies, and diagnostic methods. It is hoped that collaboration and awareness between pharmaceutical companies, water industries, and academic institutions is essential for advancing effective strategies against this severe central nervous system pathogen. © 2025 Informa UK Limited, trading as Taylor & Francis Group.
Açıklama
Anahtar Kelimeler
Central Nervous System İnfections, Patents, Naegleria Fowleri, Primary Amebic Meningoencephalitis
Kaynak
Pharmaceutical Patent Analyst
WoS Q Değeri
Scopus Q Değeri
Q3
Cilt
Sayı
Künye
Siddiqui, R., Lloyd, D., & Khan, N. A. (2025). Emerging patents versus brain eating amoebae, Naegleria fowleri. Pharmaceutical Patent Analyst, 1-6.
